Cabot (NYSE:CBT) Releases FY 2026 Earnings Guidance

Cabot (NYSE:CBTGet Free Report) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 6.000-7.00 for the period, compared to the consensus estimate of 7.610. The company issued revenue guidance of -.

Cabot Trading Down 2.4%

Cabot stock traded down $1.61 during midday trading on Monday, reaching $65.87. The stock had a trading volume of 1,018,515 shares, compared to its average volume of 416,269. Cabot has a twelve month low of $65.40 and a twelve month high of $117.46. The stock has a market capitalization of $3.50 billion, a PE ratio of 8.61 and a beta of 0.88. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.41 and a current ratio of 2.13. The stock’s 50-day simple moving average is $75.45 and its 200 day simple moving average is $76.09.

Cabot (NYSE:CBTGet Free Report) last issued its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. Cabot had a return on equity of 25.68% and a net margin of 11.14%.The firm had revenue of $923.00 million for the quarter, compared to analysts’ expectations of $957.29 million. Analysts expect that Cabot will post 7.57 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts recently weighed in on CBT shares. Mizuho reduced their target price on Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a report on Friday, October 3rd. UBS Group set a $82.00 price objective on Cabot and gave the company a “neutral” rating in a research report on Tuesday, August 5th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $85.00.

Read Our Latest Research Report on CBT

Insider Activity

In other news, CEO Sean D. Keohane sold 114,436 shares of Cabot stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the sale, the chief executive officer directly owned 361,518 shares of the company’s stock, valued at approximately $28,661,147.04. The trade was a 24.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 3.03% of the company’s stock.

Hedge Funds Weigh In On Cabot

Hedge funds have recently bought and sold shares of the company. Sivia Capital Partners LLC acquired a new position in Cabot in the second quarter worth about $279,000. Brevan Howard Capital Management LP grew its stake in Cabot by 22.3% in the second quarter. Brevan Howard Capital Management LP now owns 14,580 shares of the specialty chemicals company’s stock worth $1,094,000 after purchasing an additional 2,659 shares in the last quarter. Corient Private Wealth LLC grew its stake in Cabot by 4.5% in the second quarter. Corient Private Wealth LLC now owns 14,496 shares of the specialty chemicals company’s stock worth $1,087,000 after purchasing an additional 625 shares in the last quarter. Gabelli Funds LLC acquired a new position in Cabot in the second quarter worth about $1,004,000. Finally, Quantinno Capital Management LP boosted its stake in Cabot by 88.1% in the second quarter. Quantinno Capital Management LP now owns 9,614 shares of the specialty chemicals company’s stock valued at $721,000 after acquiring an additional 4,504 shares during the period. 93.18% of the stock is currently owned by institutional investors and hedge funds.

About Cabot

(Get Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

See Also

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.